Skip to main content
. 2021 May 22;13(11):2549. doi: 10.3390/cancers13112549

Table 3.

Operative Outcomes.

Variables N or Median % or IQR
Extent of pulmonary resection
Sub-lobar resection 5 11.4%
Lobectomy 37 84.1%
Bi-lobectomy 2 4.5%
Surgical approach
Thoracotomy 2 4.5%
VATS 37 84.1%
Conversion to thoracotomy 5 11.4%
- Difficult to dissect lymph node 3 6.8%
- Difficult to dissect pulmonary artery 2 4.5%
Combined surgical procedure 20 45.5%
Neck lymph node dissection 7 15.9%
Abdominal lymph node dissection 1 2.3%
Separate pulmonary wedge resection 4 9.1%
En-bloc resection of adjacent lobe 5 11.4%
Other procedure 3 6.8%
Duration of surgery, min 108.5 92.0–136.3
Duration of anesthesia, min 160.0 135.0–191.3
Estimated blood loss, mL
Minimal (≤50) 29 65.9%
50–200 12 27.3%
>200 3 6.8%
Complete resection (surgical field)
R0 41 93.2%
R1 1 2.3%
R2 2 4.5%
Intensive care unit stay (duration) 1 (1 day) 2.3%
Chest tube duration, days 4 3.0–5.3
Postoperative hospital stays, days 5 4.0–7.3
Complication (all) 15 34.1%
Prolonged air leak (>5 days) 5 11.4%
Chyle leakage 3 6.8%
Vocal cord palsies 2 4.5%
Bronchopleural fistula 1 2.3%
Acute kidney injury 1 2.3%
Acute lung injury 1 2.3%
Pneumonia 1 2.3%
Pneumothorax 1 2.3%
Complication (Clavien–Dindo > Gr 3) 4 9.1%
Chyle leakage 1 2.3%
Vocal cord palsies 1 2.3%
Broncho-pleural fistula 1 2.3%
Pneumothorax 1 2.3%
In-hospital mortality 0 0.0%